FN1 and Myocardial fibrosis: Furthermore, FX treatment reduced the accumulation of key fibrosis markers, including TGF-β1, fibronectin (FN), and α-smooth muscle actin (α-SMA), thus attenuating myocardial fibrosis in STZ-induced DM rats.